Baird Financial Group, Inc. Teva Pharmaceutical Industries LTD Transaction History

Baird Financial Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.33 - $9.39 $143,580 - $183,931	-19,588 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$7.9 - $10.19 $154,745 - $199,601	19,588 New	19,588 $157,000
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $96,596 - $117,344	-11,527 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$9.9 - $11.56 $114,117 - $133,252	11,527 New	11,527 $114,000
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $102,997 - $169,086	-15,773 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $24,368 - $37,977	-3,956 Reduced 20.05%	15,773 $109,000
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $143,927 - $278,637	-17,725 Reduced 47.32%	19,729 $182,000
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $206,933 - $265,772	-13,282 Reduced 26.18%	37,454 $587,000
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $19,156 - $31,301	-1,313 Reduced 2.52%	50,736 $782,000
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $173,702 - $211,561	8,248 Added 18.83%	52,049 $1.12 Million
Q2 2018 Aug 13, 2018	BUY	$16.77 - $24.71 $132,617 - $195,406	7,908 Added 22.03%	43,801 $1.07 Million
Q1 2018 May 14, 2018	BUY	$16.68 - $22.07 $161,612 - $213,836	9,689 Added 36.98%	35,893 $613,000
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $1.27 Million - $2.17 Million	-113,390 Reduced 81.23%	26,204 $497,000
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $1.2 Million - $2.5 Million	-77,638 Reduced 35.74%	139,594 $2.46 Million
Q2 2017 Aug 14, 2017	BUY	N/A	217,232	217,232 $7.22 Million

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.